Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Myke R. Green
Posaconazole for the Treatment of Oropharyngeal Candidiasis, Including Triazole-Resistant Disease, in HIV-positive Patients
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Related publications
Local Immunity in Hematological Patients With Oropharyngeal Candidiasis
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Miconazole Mucoadhesive Tablet for Oropharyngeal Candidiasis
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Multiple Resistant Phenotypes of Candida albicansCoexist During Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Oral Candidiasis in HIV+ Patients Under Treatment With Protease Inhibitors
Brazilian Oral Research
Mouse Model of Oropharyngeal Candidiasis
Nature Protocols
Biochemistry
Genetics
Molecular Biology
Renal Disease Among HIV Positive Patients in Senegal
Open Journal of Nephrology
Pulmonary Candidiasis and CD4 Count in HIV Positive Patients Seen in Jos, North Central Nigeria
African Journal of Clinical and Experimental Microbiology
Triazole Use in the Nursery: Fluconazole, Voriconazole, Posaconazole, and Ravuconazole
Current Drug Metabolism
Clinical Biochemistry
Pharmacology
Oropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida Albicans in Mice Expressing the HIV-1 Transgene
Pathogens
Immunology
Molecular Biology
Allergy
Microbiology
Microbiology
Infectious Diseases
